Technical Analysis for CRNX - Crinetics Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 24.17 -2.15% -0.53
CRNX closed down 2.15 percent on Wednesday, April 24, 2019, on approximately normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical CRNX trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Centerline Cross Bullish -2.15%
Bollinger Band Squeeze Range Contraction -2.15%
Stochastic Reached Overbought Strength -2.15%
BB Squeeze + Upper Band Touch Range Contraction -2.15%

Older signals for CRNX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.
Cancer Disease Organ Systems Endocrine System Pancreatic Cancer Acromegaly Neuroendocrinology Endocrine Diseases Neuroendocrine Tumors
Is CRNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 42.0
52 Week Low 19.23
Average Volume 75,830
200-Day Moving Average 0.0
50-Day Moving Average 23.8536
20-Day Moving Average 23.258
10-Day Moving Average 23.622
Average True Range 1.2698
ADX 15.94
+DI 18.7263
-DI 17.2355
Chandelier Exit (Long, 3 ATRs ) 21.0906
Chandelier Exit (Short, 3 ATRs ) 25.2394
Upper Bollinger Band 24.4821
Lower Bollinger Band 22.0339
Percent B (%b) 0.87
BandWidth 10.526271
MACD Line 0.0606
MACD Signal Line -0.1463
MACD Histogram 0.2069
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.20
Resistance 3 (R3) 26.21 25.56 25.86
Resistance 2 (R2) 25.56 25.04 25.55 25.74
Resistance 1 (R1) 24.86 24.72 24.54 24.85 25.63
Pivot Point 24.21 24.21 24.04 24.20 24.21
Support 1 (S1) 23.51 23.69 23.19 23.50 22.71
Support 2 (S2) 22.86 23.37 22.85 22.60
Support 3 (S3) 22.16 22.86 22.48
Support 4 (S4) 22.15